13 completed, 4 not yet recruiting, 3 unknown, 2 terminated. 26 Phase 3, 14 Phase 2.
Follow Dronabinol: new trials by email Literature Review of Dronabinol trials Research Report on Dronabinol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of Synthetic THC And Sleep Dronabinol, Placebo - Obstructive Sleep Apnea | Phase 2 / Phase 3 | Not yet recruiting | Mayo Clinic | 72 | 2026-11-01 | 2026-09-18 |
| Synthetic THC And Blood Pressure Dronabinol, Placebo - Blood Pressure | Phase 2 / Phase 3 | Not yet recruiting | Mayo Clinic | 50 | 2026-10-01 | 2026-09-11 |
| Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial Dronabinol Capsules, Epidiolex 100 mg/mL Oral Solution, Placebo Dronabinol - Opioid Use Disorder | Phase 3 | Not yet recruiting | Montefiore Medical Center | 40 | 2026-10-01 | 2026-06-09 |
| To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease Dronabinol Oral Solution, Placebo Control - Agitation in Dementia | Phase 2 / Phase 3 | Not yet recruiting | Benuvia Therapeutics Inc. | 140 | 2026-05-01 | 2026-02-25 |
| Safety and Efficacy of Oral Cannabis in Chronic Spine Pain THC/CBD, THC, Placebo - Back Pain, Neck Pain | Phase 3 | Recruiting | University of Colorado, Denver | 157 | 2026-01-01 | 2026-01-23 |
| Reducing Breathlessness With Dronabinol in COPD Patients Dronabinol 2.5mg Capsule, Placebo - COPD, Breathlessness | Phase 3 | Completed | Vejle Hospital | 30 | 2025-02-26 | 2026-10-05 |
| RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA IHL-42X Low Dose, IHL-42X High Dose, Placebo - Obstructive Sleep Apnea | Phase 2 / Phase 3 | Completed | Incannex Healthcare Ltd | 121 | 2024-05-02 | 2026-07-27 |
| Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder NTI164 - Autism Spectrum Disorder | Phase 2 / Phase 3 | Completed | Fenix Innovation Group | 54 | 2022-11-30 | 2026-09-10 |
| Characterization of the Pharmacodynamic Response to Vaped THC THC or Placebo - Vaping, THC | Phase 3 | Withdrawn | Massachusetts General Hospital | 2022-11-01 | 2022-02-11 | |
| Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine - Placebo oral drops, Cannabidiol + Cannabigerol + Tetrahydrocannabinol 133/66/4mg - Chronic Migraine, Headache, Overuse Headache Medication | Phase 2 / Phase 3 | Terminated | Hospital Israelita Albert Einstein | 110 | 2022-10-18 | 2025-02-24 |
| Dronabinol After Arthroscopic Surgery Dronabinol, Placebo - Knee Osteoarthritis, Knee Injuries | Phase 3 | Active not recruiting | Northwestern University | 30 | 2022-06-28 | 2026-09-25 |
| CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) cannabidiol and tetrahydrocannabinol, Placebo - Fibromyalgia | Phase 2 / Phase 3 | Unknown | FG Brasil LTDA | 40 | 2022-04-15 | 2022-04-11 |
| A RCT Comparing Dronabinol to a Placebo for Post-operative Pain in Total Joint Arthroplasty Dronabinol, Placebo - Osteoarthritis, Knee | Phase 3 | Unknown | Colorado Joint Replacement | 460 | 2020-02-05 | 2023-01-10 |
| Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer Dronabinol in Oral Dosage Form, Placebo in Oral Dosage Form - Pancreatic Cancer Non-resectable, Chemotherapy-induced Nausea and Vomiting | Phase 3 | Completed | Arbeitsgemeinschaft medikamentoese Tumortherapie | 109 | 2019-12-16 | 2025-04-10 |
| Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors Dronabinol, Placebo - Trichotillomania, Skin-Picking | Phase 2 / Phase 3 | Completed | University of Chicago | 50 | 2018-10-01 | 2022-06-02 |
| The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis Medical Marijuana, Placebo - Multiple Sclerosis | Phase 2 / Phase 3 | Withdrawn | Colorado State University | 2017-01-01 | 2018-07-18 | |
| Anesthetic Premedication With a Cannabis Extract (Cannapremed) Tetrahydrocannabinol, Dummy oromucosal - Pain, Postoperative, Postoperative Nausea and Vomiting | Phase 2 / Phase 3 | Unknown | Hadassah Medical Organization | 200 | 2015-05-01 | 2024-02-28 |
| Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia Dronabinol, Clonidine, Placebo - Cannabis Dependence, Marijuana Dependence | Phase 2 / Phase 3 | Terminated | Mclean Hospital | 12 | 2012-05-01 | 2018-08-29 |
| Dronabinol Naltrexone Treatment for Opioid Dependence injectable naltrexone and dronabinol, Naltrexone and placebo - Opioid Dependence | Phase 2 / Phase 3 | Completed | New York State Psychiatric Institute | 60 | 2010-01-01 | 2018-06-18 |
| Combined Pharmacotherapy for Cannabis Dependency Dronabinol, Placebo, Lofexidine - Cannabis Dependence, Marijuana Dependence | Phase 2 / Phase 3 | Completed | New York State Psychiatric Institute | 156 | 2010-01-01 | 2019-04-24 |
Showing 20 of 26. Sign in to see all of them.
Marijuana Abuse (5) · Vomiting (3) · Multiple Sclerosis (2) · Nausea (2) · Opioid-Related Disorders (2) · Osteoarthritis, Knee (2) · Sleep Apnea, Obstructive (2) · Aberrant Motor Behavior in Dementia (1) · Anorexia Nervosa (1) · Anxiety Disorders (1) · Autism Spectrum Disorder (1) · Back Pain (1) · Bronchiolitis Obliterans Syndrome (1) · Chronic Pain (1) · Dyspnea (1)
Mayo Clinic (2) · New York State Psychiatric Institute (2) · Arbeitsgemeinschaft medikamentoese Tumortherapie (1) · Benuvia Therapeutics Inc. (1) · Bionorica Research GmbH (1) · Brigham and Women's Hospital (1) · Colorado Joint Replacement (1) · Colorado State University (1) · FG Brasil LTDA (1) · Fenix Innovation Group (1) · Hadassah Medical Organization (1) · Hospital Israelita Albert Einstein (1) · Incannex Healthcare Ltd (1) · Jazz Pharmaceuticals (1) · M.D. Anderson Cancer Center (1)
United States (14) · Australia (2) · Denmark (2) · Germany (2) · Austria (1) · Brazil (1) · Israel (1) · United Kingdom (1)
Adam Bisaga, MD (1) · Alexandre O Kaup, MD, PhD (1) · Amal I. Melhem-Bertrandt, MD (1) · Andries Alin, physician (1) · Deepika Slawek, MD, MPH, MS (1) · Eden Evins, MD, MPH (1) · Elyad Davidson, M.D. (1) · Emily Lindley, PhD (1) · Felix Keil, Prof.MD (1) · Frances R Levin, M.D. (1) · Jason M Jennings, MD DPT (1) · Jeremy R Johnson, MB ChB (1) · Jon E Grant, JD, MD, MPH (1) · Kevin P Hill, MD, MHS (1)
PMID 19896326, PMID 29457671, PMID 34582562, PMID 34825898, PMID 36877132, PMID 41698715
2025 (1), P50DA009236 (1), R01DA027124 (1), R34DA063987 (1)